Evidence map›Paper›PMID 33128002›Full record

ArticleCommunications biology2020

Chemicals orchestrate reprogramming with hierarchical activation of master transcription factors primed by endogenous Sox17 activation.

Zhenghao Yang, Xiaochan Xu, Chan Gu, Jun Li, Qihong Wu, Can Ye, Alexander Valentin Nielsen, Lichao Mao, Junqing Ye, Ke Bai and 3 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Zhenghao YangState Key Laboratory of Natural and Biomimetic Drugs, MOE Key Laboratory of Cell Proliferation and Differentiation, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, Peking University, 100871, Beijing, China.
Xiaochan XuPeking-Tsinghua Center for Life Sciences, Peking University, 100871, Beijing, China.
Chan GuCenter for Translational Medicine, Ministry of Education Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.ORCID 0000-0002-4212-2394
Jun LiPeking-Tsinghua Center for Life Sciences, Peking University, 100871, Beijing, China.ORCID 0000-0001-9668-343X
Qihong WuCenter for Translational Medicine, Ministry of Education Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
Can YeBioMed-X center, Peking University, 100871, Beijing, China.
Alexander Valentin NielsenThe Niels Bohr Institute, University of Copenhagen, Blegdamsvej 17, 2100, Copenhagen, Denmark.ORCID 0000-0002-2830-9283
Lichao MaoState Key Laboratory of Natural and Biomimetic Drugs, MOE Key Laboratory of Cell Proliferation and Differentiation, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, Peking University, 100871, Beijing, China.
Junqing YeBoehringer Ingelheim International GmbH (China), 100027, Beijing, China.
Ke BaiState Key Laboratory of Natural and Biomimetic Drugs, MOE Key Laboratory of Cell Proliferation and Differentiation, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, Peking University, 100871, Beijing, China.
Fan GuoCenter for Translational Medicine, Ministry of Education Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, 610041, Chengdu, Sichuan, China. guofan@scu.edu.cn.ORCID 0000-0002-0165-073X
Chao TangPeking-Tsinghua Center for Life Sciences, Peking University, 100871, Beijing, China. tangc@pku.edu.cn.ORCID 0000-0003-1474-3705
Yang ZhaoState Key Laboratory of Natural and Biomimetic Drugs, MOE Key Laboratory of Cell Proliferation and Differentiation, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, Peking University, 100871, Beijing, China. yangzhao@pku.edu.cn.ORCID 0000-0002-0856-2724
Peking University · CNSichuan University · CNBoehringer Ingelheim (China) · CNUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mouse somatic cells can be chemically reprogrammed into pluripotent stem cells (CiPSCs) through an intermediate extraembryonic endoderm (XEN)-like state. However, it is elusive how the chemicals orchestrate the cell fate alteration. In this study, we analyze molecular dynamics in chemical reprogramming from fibroblasts to a XEN-like state. We find that Sox17 is initially activated by the chemical cocktails, and XEN cell fate specialization is subsequently mediated by Sox17 activated expression of other XEN master genes, such as Sall4 and Gata4. Furthermore, this stepwise process is differentially regulated. The core reprogramming chemicals CHIR99021, 616452 and Forskolin are all necessary for Sox17 activation, while differently required for Gata4 and Sall4 expression. The addition of chemical boosters in different phases further improves the generation efficiency of XEN-like cells. Taken together, our work demonstrates that chemical reprogramming is regulated in 3 distinct "prime-specify-transit" phases initiated with endogenous Sox17 activation, providing a new framework to understand cell fate determination.

Indexed as

AdenosineAnimalsBenzoatesBone Morphogenetic ProteinsCell LineageCellular ReprogrammingChalconesColforsinEndodermFibroblastsGene Expression RegulationHMGB ProteinsMice, Inbred ICRPhenylurea CompoundsPyridinesPyrimidines3,5-di-tert-butylchalcone 4'-carboxylic acidAdenosineAm 580BenzoatesBone Morphogenetic ProteinsChalconesChir 99021ColforsinEPZ004777HMGB ProteinsPhenylurea CompoundsPyridinesPyrimidinesSox17 protein, mouseSOXF Transcription FactorsTetrahydronaphthalenesTranscription Factors

Identifiers

PMID33128002
PMCPMC7603307
OpenAlexW3096786682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.